Primary CNS Lymphoma: Progress With Dose-Intensive Consolidation
Abstract
The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors’ suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.
© 2022 by American Society of Clinical OncologySUPPORT
Supported by NIH R01CA139-83-01A1.
AUTHOR'S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
Primary CNS Lymphoma: Progress with Dose-Intensive Consolidation
The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
James L. Rubenstein
Consulting or Advisory Role: Incyte
Research Funding: Incyte, NURIX
No other potential conflicts of interest were reported.
留言 (0)